Here’s Why Progyny (PGNY) Outperformed in Q2
Polen Capital, an investment management company, released its “Polen U.S. Small Company Growth Strategy” second-quarter investor letter. A copy of the same can be downloaded here.
Progyny Inc. (PGNY)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Owls Nest Partners Philip Timon | 1,353,643 | $53,252,316 | +16% | 16.31% |
| 2. | Citadel Investment Group Ken Griffin | 1,000,749 | $39,369,466 | -14% | 0% |
| 3. | GLG Partners Noam Gottesman | 976,348 | $38,409,530 | 0.11% | |
| 4. | Cercano Management Chris Orndorff | 709,356 | $27,906,065 | +25% | 0.96% |
| 5. | Cowbird Capital Scott Coulter | 701,220 | $27,585,995 | -20% | 11.42% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $13.00 | 76,923 | Director | 76,923 | 2019-10-29 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $41.08 | 2,900,000 | Other | 6,350,000 | 2023-08-07 | Filing | |
| $38.95 | 2,096 | Officer, Director | 1 | 2023-07-14 | Filing | |
| $38.95 | 17,990 | Officer, Director | 207,947 | 2023-07-14 | Filing | |
| $38.95 | 67,457 | Officer, Director | 70,806 | 2023-07-13 | Filing | |
| $38.64 | 38,687 | Officer, Director | 70,806 | 2023-07-12 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 9,558,333 | $376,024,821 | 0.01% | |
| 2. | 9,250,000 | $363,895,000 | 5.34% | |
| 3. | 7,592,444 | $298,686,748 | 0% | |
| 4. | 5,074,615 | $199,635,354 | 89.22% | |
| 5. | 4,046,908 | $159,205,376 | 0.14% |
News See All
Progyny, Inc. (NASDAQ:PGNY) Q2 2023 Earnings Call Transcript
Operator: Good day, everyone, and welcome to the Progyny, Inc. Second Quarter 2023 Earnings Call. [Operator Instructions] It is now my pleasure to turn the floor over to your host, James Hart.
Progyny, Inc. (NASDAQ:PGNY) Q1 2023 Earnings Call Transcript
James Hart: Thank you, John, and good afternoon, everyone. Welcome to our first quarter conference call.
Progyny, Inc. (NASDAQ:PGNY) Q4 2022 Earnings Call Transcript
James Hart: Thank you, John and good afternoon, everyone. Welcome to our fourth quarter conference call.
12 High Growth Healthcare Stocks to Buy
The healthcare sector proved its mettle in 2022.
Should You Retain Progyny (PGNY) Stock?
Polen Capital, an investment management company, released its “Polen U.S. Small Company Growth Strategy” fourth-quarter investor letter. A copy of the same can be downloaded here.
Does Progyny (PGNY) Have High Growth Prospects?
ClearBridge Investments, an investment management company, released its “ClearBridge Sustainability Leaders Strategy” third 2022 investor letter. A copy of the same can be downloaded here.
Is Progyny (PGNY) a Rapidly Growing Business?
Polen Capital, an investment management company, released its “Polen U.S. Small Company Growth Strategy” third-quarter 2022 investor letter. A copy of the same can be downloaded here.
Should You Invest in Progyny (PGNY) Now?
Polen Capital, an investment management company, released its “Polen U.S. Small Company Growth Fund” second quarter 2022 investor letter. A copy of the same can be downloaded here.
Here's Why Progyny (PGNY)'s Stock Dropped in the Second Quarter
Baron Funds, an asset management company, released its “Baron Discovery Fund” second quarter 2022 investor letter. A copy of the same can be downloaded here.
Billionaire Hedge Funds
